These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 353597)

  • 1. The treatment of hypertension with verapamil.
    Lewis GR; Morley KD; Lewis BM; Bones PJ
    N Z Med J; 1978 May; 87(612):351-4. PubMed ID: 353597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of long-acting propranolol and verapamil on blood pressure, platelet function, metabolic and rheological properties in hypertension.
    Ding YA; Chou TC; Lin KC
    J Hum Hypertens; 1994 Apr; 8(4):273-8. PubMed ID: 8021907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Verapamil SR and propranolol LA: a comparison of efficacy and side effects in the treatment of mild to moderate hypertension.
    Bochsler JA; Simmons RL; Ward PJ; Chester PC; Latham AN
    J Hum Hypertens; 1988 Mar; 1(4):305-10. PubMed ID: 3065507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparisons of verapamil administration twice and three times daily in hypertension.
    Salmela PI; Gordin A; Salo H; Ottoila P; Jounela AJ
    Ann Clin Res; 1988; 20(3):195-200. PubMed ID: 3058014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of equal-weight oral dosages of verapamil hydrochloride and diltiazem hydrochloride in patients with mild to moderate hypertension.
    Hollifield JW; Heusner JJ; DesChamps M; Gray J; Spyker DA; Peace KE; Dickson B
    Clin Pharm; 1988 Feb; 7(2):129-34. PubMed ID: 3280220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A double-blind comparison of verapamil and labetalol in hypertensive patients with coexisting chronic obstructive airways disease.
    Anavekar SN; Barter C; Adam WR; Doyle AE
    J Cardiovasc Pharmacol; 1982; 4 Suppl 3():S374-7. PubMed ID: 6184571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Verapamil in the management of chronic hypertension.
    Lewis GR
    Clin Invest Med; 1980; 3(1-2):175-7. PubMed ID: 6110499
    [No Abstract]   [Full Text] [Related]  

  • 8. Dose-response curves in antihypertensive combination therapy: results of a controlled clinical trial.
    Letzel H; Bluemner E
    J Hypertens Suppl; 1990 Sep; 8(4):S83-6. PubMed ID: 2258790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the efficacy of an ACE-inhibitor and a calcium channel blocker in hypertensive asthmatics. A preliminiary report.
    Riska H; Stenius-Aaniala B; Sovijärvi AR
    Postgrad Med J; 1986; 62 Suppl 1():52-3. PubMed ID: 3317340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Verapamil and beta-blockers in hypertension: a beneficial drug interaction?
    Dargie HJ
    Br J Clin Pract Suppl; 1985 Jun; 42():44-7. PubMed ID: 3929827
    [No Abstract]   [Full Text] [Related]  

  • 11. The antihypertensive efficacy of verapamil in the elderly evaluated by ambulatory blood pressure measurement.
    Cox JP; O'Boyle CA; Mee F; Kelly J; Atkins N; Coakley D; O'Brien ET; O'Malley K
    J Hum Hypertens; 1988 Jun; 2(1):41-7. PubMed ID: 3070032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of nonsteroidal anti-inflammatory drugs on blood pressures of patients with hypertension controlled by verapamil.
    Houston MC; Weir M; Gray J; Ginsberg D; Szeto C; Kaihlenen PM; Sugimoto D; Runde M; Lefkowitz M
    Arch Intern Med; 1995 May; 155(10):1049-54. PubMed ID: 7748048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of amlodipine, verapamil and placebo in the treatment of mild to moderate hypertension. Amlodipine Study Group.
    Lorimer AR; Smedsrud T; Walker P; Tyler HM
    J Hum Hypertens; 1989 Jun; 3(3):191-6. PubMed ID: 2527993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of sustained-release verapamil: automatic ambulatory blood pressure monitoring.
    Zachariah PK; Sheps SG; Schriger A
    J Clin Hypertens; 1986 Sep; 2(3 Suppl):133S-142S. PubMed ID: 3540223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Verapamil - an alternative in hypertension therapy].
    Ottander C
    Lakartidningen; 1983 Oct; 80(40):3661-3. PubMed ID: 6358730
    [No Abstract]   [Full Text] [Related]  

  • 16. [Hypotensive efficacy of verapamil alone and in combination with a diuretic in the treatment of essential hypertension in geriatric patients].
    Latini R; Pierandrei G; Achilli L; Lombi V; D'Amico F
    G Ital Cardiol; 1987 Feb; 17(2):144-8. PubMed ID: 3301500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antihypertensive effects of verapamil, captopril and their combination at rest and during dynamic exercise.
    Di Somma S; Petitto M; Liguori V; Carotenuto A; Paulucci A; De Divitiis O
    Arzneimittelforschung; 1992 Feb; 42(2):103-7. PubMed ID: 1610414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical evaluation of the effect of verapamil in hypertensive patients].
    Gelman A; de Albuquerque EM; Reynaldo Stella S; Draibe SA; Ajzen H
    Arq Bras Cardiol; 1983 Jan; 40(1):69-71. PubMed ID: 6351814
    [No Abstract]   [Full Text] [Related]  

  • 19. Hydrochlorothiazide and verapamil in the treatment of hypertension. The Verapamil Versus Diuretic (VERDI) Trial Research Group.
    Holzgreve H; Distler A; Michaelis J; Philipp T; Wellek S
    J Cardiovasc Pharmacol; 1991; 18 Suppl 6():S33-7. PubMed ID: 1725915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new sustained-release formulation of verapamil in the treatment of hypertension.
    Midtbo KA; Hals O; Lauve O
    J Clin Hypertens; 1986 Sep; 2(3 Suppl):125S-132S. PubMed ID: 3540222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.